vs

Side-by-side financial comparison of High-Trend International Group (HTCO) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $99.4M, roughly 1.5× High-Trend International Group). Tarsus Pharmaceuticals, Inc. runs the higher net margin — -5.5% vs -13.4%, a 7.9% gap on every dollar of revenue. On growth, High-Trend International Group posted the faster year-over-year revenue change (185.2% vs 128.4%). Tarsus Pharmaceuticals, Inc. produced more free cash flow last quarter ($13.0M vs $6.5M).

Motor Trend Group, LLC is a media company that specializes in enthusiast brands, such as Motor Trend and Hot Rod. Headquartered in El Segundo, California, it was a subsidiary of the TNT Sports division of Warner Bros. Discovery (WBD) until being sold to Hearst Communications in 2024.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

HTCO vs TARS — Head-to-Head

Bigger by revenue
TARS
TARS
1.5× larger
TARS
$151.7M
$99.4M
HTCO
Growing faster (revenue YoY)
HTCO
HTCO
+56.8% gap
HTCO
185.2%
128.4%
TARS
Higher net margin
TARS
TARS
7.9% more per $
TARS
-5.5%
-13.4%
HTCO
More free cash flow
TARS
TARS
$6.5M more FCF
TARS
$13.0M
$6.5M
HTCO

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
HTCO
HTCO
TARS
TARS
Revenue
$99.4M
$151.7M
Net Profit
$-13.3M
$-8.4M
Gross Margin
4.0%
Operating Margin
-12.5%
-5.3%
Net Margin
-13.4%
-5.5%
Revenue YoY
185.2%
128.4%
Net Profit YoY
-1624.0%
63.8%
EPS (diluted)
$-3.29
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTCO
HTCO
TARS
TARS
Q4 25
$151.7M
Q3 25
$118.7M
Q2 25
$99.4M
$102.7M
Q1 25
$78.3M
Q4 24
$66.4M
Q3 24
$48.1M
Q2 24
$34.9M
$40.8M
Q1 24
$27.6M
Net Profit
HTCO
HTCO
TARS
TARS
Q4 25
$-8.4M
Q3 25
$-12.6M
Q2 25
$-13.3M
$-20.3M
Q1 25
$-25.1M
Q4 24
$-23.1M
Q3 24
$-23.4M
Q2 24
$-771.7K
$-33.3M
Q1 24
$-35.7M
Gross Margin
HTCO
HTCO
TARS
TARS
Q4 25
Q3 25
Q2 25
4.0%
Q1 25
Q4 24
Q3 24
Q2 24
7.0%
Q1 24
Operating Margin
HTCO
HTCO
TARS
TARS
Q4 25
-5.3%
Q3 25
-12.2%
Q2 25
-12.5%
-21.6%
Q1 25
-33.5%
Q4 24
-36.8%
Q3 24
-52.3%
Q2 24
0.4%
-81.6%
Q1 24
-136.5%
Net Margin
HTCO
HTCO
TARS
TARS
Q4 25
-5.5%
Q3 25
-10.6%
Q2 25
-13.4%
-19.8%
Q1 25
-32.1%
Q4 24
-34.8%
Q3 24
-48.7%
Q2 24
-2.2%
-81.6%
Q1 24
-129.4%
EPS (diluted)
HTCO
HTCO
TARS
TARS
Q4 25
$-0.17
Q3 25
$-0.30
Q2 25
$-3.29
$-0.48
Q1 25
$-0.64
Q4 24
$-0.57
Q3 24
$-0.61
Q2 24
$-0.37
$-0.88
Q1 24
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTCO
HTCO
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$13.2M
$417.3M
Total DebtLower is stronger
$1.0M
$72.4M
Stockholders' EquityBook value
$21.2M
$343.4M
Total Assets
$41.7M
$562.2M
Debt / EquityLower = less leverage
0.05×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTCO
HTCO
TARS
TARS
Q4 25
$417.3M
Q3 25
$401.8M
Q2 25
$13.2M
$381.1M
Q1 25
$407.9M
Q4 24
$291.4M
Q3 24
$317.0M
Q2 24
$3.4M
$323.6M
Q1 24
$298.5M
Total Debt
HTCO
HTCO
TARS
TARS
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$1.0M
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$2.0M
$71.6M
Q1 24
$29.9M
Stockholders' Equity
HTCO
HTCO
TARS
TARS
Q4 25
$343.4M
Q3 25
$335.1M
Q2 25
$21.2M
$332.6M
Q1 25
$342.5M
Q4 24
$224.5M
Q3 24
$237.5M
Q2 24
$-5.3M
$252.2M
Q1 24
$275.2M
Total Assets
HTCO
HTCO
TARS
TARS
Q4 25
$562.2M
Q3 25
$534.6M
Q2 25
$41.7M
$495.0M
Q1 25
$500.8M
Q4 24
$377.0M
Q3 24
$376.3M
Q2 24
$13.4M
$376.8M
Q1 24
$349.3M
Debt / Equity
HTCO
HTCO
TARS
TARS
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.05×
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTCO
HTCO
TARS
TARS
Operating Cash FlowLast quarter
$6.5M
$19.3M
Free Cash FlowOCF − Capex
$6.5M
$13.0M
FCF MarginFCF / Revenue
6.6%
8.6%
Capex IntensityCapex / Revenue
0.0%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTCO
HTCO
TARS
TARS
Q4 25
$19.3M
Q3 25
$18.3M
Q2 25
$6.5M
$-29.4M
Q1 25
$-20.7M
Q4 24
$-22.2M
Q3 24
$-8.7M
Q2 24
$-3.5M
$-14.4M
Q1 24
$-37.8M
Free Cash Flow
HTCO
HTCO
TARS
TARS
Q4 25
$13.0M
Q3 25
$16.3M
Q2 25
$6.5M
$-30.4M
Q1 25
$-21.2M
Q4 24
$-22.3M
Q3 24
$-8.9M
Q2 24
$-15.4M
Q1 24
$-38.0M
FCF Margin
HTCO
HTCO
TARS
TARS
Q4 25
8.6%
Q3 25
13.8%
Q2 25
6.6%
-29.6%
Q1 25
-27.1%
Q4 24
-33.5%
Q3 24
-18.6%
Q2 24
-37.8%
Q1 24
-137.5%
Capex Intensity
HTCO
HTCO
TARS
TARS
Q4 25
4.2%
Q3 25
1.6%
Q2 25
0.0%
1.0%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
0.6%
Q2 24
2.5%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons